"Designing Growth Strategies is in our DNA"

Brain Tumor Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, and Others), By Indication (Pituitary, Meningioma, Glioma, and Others), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI105025

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Brain Cancer, Key Region, 2020/2021
    2. Key Industry Developments - Mergers, Partnership, Acquisitions
    3. Overview of the Regulatory Scenario by Key Region/Countries
    4. New Product Launches by Key Players
    5. Impact of COVID-19 on Brain Tumor Drugs Market
  5. Global Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Indication
      2. Canada
        1. By Indication
  7. Europe Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Germany
        1. By Indication
      2. U.K.
        1. By Indication
      3. France
        1. By Indication
      4. Spain
        1. By Indication
      5. Italy
        1. By Indication
      6. Scandinavia
        1. By Indication
      7. Rest of Europe
        1. By Indication
  8. Asia Pacific Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Indication
      2. China
        1. By Indication
      3. India
        1. By Indication
      4. Australia
        1. By Indication
      5. Southeast Asia
        1. By Indication
      6. Rest of Asia Pacific
        1. By Indication
  9. Latin America Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Indication
      2. Mexico
        1. By Indication
      3. Rest of Latin America
        1. By Indication
  10. Middle East & Africa Brain Tumor Drugs Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Therapy
      1. Targeted Therapy
      2. Chemotherapy
      3. Immunotherapy
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Pituitary Tumors
      2. Meningioma
      3. Glioblastoma
      4. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Indication
      2. South Africa
        1. By Indication
      3. Rest of Middle East & Africa
        1. By Indication
  11. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Merck & Co. Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Amneal Pharmaceuticals LLC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Amgen Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. NextSource Pharmaceuticals, LLC
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Emcure Pharmaceuticals
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Global Brain Tumor Drugs Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 2:  Global Brain Tumor Drugs Market Value Share (%), by Therapy, 2021 & 2029

Figure 3:  Global Brain Tumor Drugs Market Forecast (USD billion), by Targeted Therapy, 2018-2029

Figure 4:  Global Brain Tumor Drugs Market Forecast (USD billion), by Chemotherapy, 2018-2029

Figure 5:  Global Brain Tumor Drugs Market Forecast (USD billion), by Immunotherapy, 2018-2029

Figure 6:  Global Brain Tumor Drugs Market Forecast (USD billion), by Others, 2018-2029

Figure 7:  Global Brain Tumor Drugs Market Value Share (%), by Indication, 2021 & 2029

Figure 8:  Global Brain Tumor Drugs Market Forecast (USD billion), by Pituitary Tumors, 2018-2029

Figure 9:  Global Brain Tumor Drugs Market Forecast (USD billion), by Meningioma, 2018-2029

Figure 10:  Global Brain Tumor Drugs Market Forecast (USD billion), by Glioblastoma, 2018-2029

Figure 11:  Global Brain Tumor Drugs Market Forecast (USD billion), by Others, 2018-2029

Figure 12:  Global Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021 & 2029

Figure 13:  Global Brain Tumor Drugs Market Forecast (USD billion), by Hospital Pharmacy, 2018-2029

Figure 14:  Global Brain Tumor Drugs Market Forecast (USD billion), by Retail & Online Pharmacy, 2018-2029

Figure 15:  Global Brain Tumor Drugs Market Value (USD billion), by Region, 2021 & 2029

Figure 16:  North America Brain Tumor Drugs Market Value (USD billion), by Therapy, 2021 & 2029

Figure 17:  North America Brain Tumor Drugs Market Value Share (%), by Therapy, 2021

Figure 18:  North America Brain Tumor Drugs Market Value (USD billion), by Indication, 2021 & 2029

Figure 19:  North America Brain Tumor Drugs Market Value Share (%), by Indication, 2021

Figure 20:  North America Brain Tumor Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 21:  North America Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 22:  North America Brain Tumor Drugs Market Value (USD billion), By Country, 2021 & 2029

Figure 23:  North America Brain Tumor Drugs Market Value Share (%), By Country, 2021

Figure 24:  Europe Brain Tumor Drugs Market Value (USD billion), by Therapy, 2021 & 2029

Figure 25:  Europe Brain Tumor Drugs Market Value Share (%), by Therapy, 2021

Figure 26:  Europe Brain Tumor Drugs Market Value (USD billion), by Indication, 2021 & 2029

Figure 27:  Europe Brain Tumor Drugs Market Value Share (%), by Indication, 2021

Figure 28:  Europe Brain Tumor Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 29:  Europe Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 30:  Europe Brain Tumor Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 31:  Europe Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2021

Figure 32:  Asia Pacific Brain Tumor Drugs Market Value (USD billion), by Therapy, 2021 & 2029

Figure 33:  Asia Pacific Brain Tumor Drugs Market Value Share (%), by Therapy, 2021

Figure 34:  Asia Pacific Brain Tumor Drugs Market Value (USD billion), by Indication, 2021 & 2029

Figure 35:  Asia Pacific Brain Tumor Drugs Market Value Share (%), by Indication, 2021

Figure 36:  Asia Pacific Brain Tumor Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 37:  Asia Pacific Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 38:  Asia Pacific Brain Tumor Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 39:  Asia Pacific Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2021

Figure 40:  Latin America Brain Tumor Drugs Market Value (USD billion), by Therapy, 2021 & 2029

Figure 41:  Latin America Brain Tumor Drugs Market Value Share (%), by Therapy, 2021

Figure 42:  Latin America Brain Tumor Drugs Market Value (USD billion), by Indication, 2021 & 2029

Figure 43:  Latin America Brain Tumor Drugs Market Value Share (%), by Indication, 2021

Figure 44:  Latin America Brain Tumor Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 45:  Latin America Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 46:  Latin America Brain Tumor Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 47:  Latin America Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2021

Figure 48:  Middle East & Africa Brain Tumor Drugs Market Value (USD billion), by Therapy, 2021 & 2029

Figure 49:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), by Therapy, 2021

Figure 50:  Middle East & Africa Brain Tumor Drugs Market Value (USD billion), by Indication, 2021 & 2029

Figure 51:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), by Indication, 2021

Figure 52:  Middle East & Africa Brain Tumor Drugs Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 53:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), by Distribution Channel, 2021

Figure 54:  Middle East & Africa Brain Tumor Drugs Market Value (USD billion), By Country/ Sub-region, 2021 & 2029

Figure 55:  Middle East & Africa Brain Tumor Drugs Market Value Share (%), By Country/ Sub-region, 2021

Figure 56:  Global Brain Tumor Drugs Market Share (%), By Company, 2021

Table 1:  Global Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 2:  Global Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 3:  Global Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 4:  Global Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Region, 2018-2029

Table 5:  North America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 6:  North America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 7:  North America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 8:  North America Brain Tumor Drugs Market Revenue (USD billion) Forecast, By Country, 2018-2029

Table 9:  U.S. Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 10:  Canada Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 11:  Europe Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 12:  Europe Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 13:  Europe Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 14:  Europe Brain Tumor Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 15:  Germany Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 16:  U.K. Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 17:  France Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 18:  Italy Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 19:  Spain Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 20:  Scandinavia Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 21:  Rest of Europe Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 22:  Asia Pacific Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 23:  Asia Pacific Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 24:  Asia Pacific Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 25:  Asia Pacific Brain Tumor Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 26:  Japan Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 27:  India Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 28:  China Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 29:  Australia Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 30:  Southeast Asia Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 31:  Rest of Asia Pacific Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 32:  Latin America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 33:  Latin America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 34:  Latin America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 35:  Latin America Brain Tumor Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 36:  Brazil Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 37:  Mexico Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 38:  Rest of Latin America Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 39:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Therapy, 2018-2029

Table 40:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 41:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2018-2029

Table 42:  Middle East & Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2018-2029

Table 43:  GCC Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 44:  South Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Table 45:  Rest of Middle East & Africa Brain Tumor Drugs Market Revenue (USD billion) Forecast, by Indication, 2018-2029

Booklet
  • Dec, 2022
  • 2021
  • 2018-2020
  • 181

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X